Cullinan Therapeutics (CGEM) Accumulated Expenses (2019 - 2026)
Cullinan Therapeutics' Accumulated Expenses was $36.24 million in Q2 2026, up 49.7% from $24.2 million a year earlier and up 13.5% from the prior quarter.
Cullinan Therapeutics (CGEM) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Cullinan Therapeutics came in at $36.12 million, up 30.6% from FY2024.
- Accumulated Expenses has now increased for five consecutive years, with a five-year compound annual growth rate of 50.7% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $27.66 million in FY2024 (+14.3%), $24.2 million in FY2023 (+71.2%), $14.14 million in FY2022 (+64.8%) and $8.58 million in FY2021 (+84.8%).
- The Q2 2026 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2020.
- Compared with a year earlier, Accumulated Expenses has increased for seven straight quarters, with growth averaging 28.7% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2022 (growth of 181.1%); the worst was Q1 2024 (a decline of 8.1%).
- Per Business Quant data, CGEM's Accumulated Expenses in the three quarters before Q2 2026 was $31.92 million (Q1 2026), $36.12 million (Q4 2025) and $29.85 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Cullinan Therapeutics | 722.60 Mn | -1.13 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.14 Mn |
| Jun 30, 2026 | 36.24 Mn |
| Mar 31, 2026 | 31.92 Mn |
| Dec 31, 2025 | 36.12 Mn |
| Sep 30, 2025 | 29.85 Mn |
| Jun 30, 2025 | 24.20 Mn |
| Mar 31, 2025 | 22.60 Mn |
| Dec 31, 2024 | 27.66 Mn |
| Sep 30, 2024 | 20.83 Mn |
| Jun 30, 2024 | 20.71 Mn |
| Mar 31, 2024 | 16.89 Mn |
| Dec 31, 2023 | 24.20 Mn |
| Sep 30, 2023 | 20.95 Mn |
| Jun 30, 2023 | 15.53 Mn |
| Mar 31, 2023 | 18.38 Mn |
| Dec 31, 2022 | 14.14 Mn |
| Sep 30, 2022 | 13.51 Mn |
| Jun 30, 2022 | 11.90 Mn |
| Mar 31, 2022 | 10.43 Mn |
| Dec 31, 2021 | 8.58 Mn |
Cullinan Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CGEM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();